Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Russell

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 19, 2005
Immunologic uniqueness of the genital tract: challenge for vaccine developmentJiri Mestecky, Zina Moldoveanu, Michael W Russell
Frontiers in Microbiology|August 12, 2011
New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the hostYingru Liu, Brandon Feinen, Michael W Russell
Mbio|August 29, 2024
Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesisMichael W Russell, Mogens Kilian, Jiri Mestecky
Clinical and Vaccine Immunology : CVI|November 8, 2013
Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometryWeiwei Zhao, Hans Minderman, Michael W Russell
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Perspectives on mucosal vaccines: is mucosal tolerance a barrier?Jiri Mestecky, Michael W Russell, Charles O Elson
The Journal of Infectious Diseases|September 20, 2013
Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12Yingru Liu, Nejat K Egilmez, Michael W Russell
Iucrdata|November 8, 2023
6,7-Diphenyl-5-thia-7-aza-spiro-[2.6]nonan-8-one 5,5-dioxideHemant P Yennawar, Michael W Russell, Lee J Silverberg
Vaccine|September 11, 2013
Vaccines against gonorrhea: current status and future challengesAnn E Jerse, Margaret C Bash, Michael W Russell
Infection and Immunity|June 24, 2005
Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in miceGregory A Price, Michael W Russell, Cynthia Nau Cornelissen
Biochemical and Biophysical Research Communications|July 29, 2008
ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21Michael W Russell, Mohamed A Soliman, David Schriemer, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 19, 2005
Immunologic uniqueness of the genital tract: challenge for vaccine developmentJiri Mestecky, Zina Moldoveanu, Michael W Russell
Frontiers in Microbiology|August 12, 2011
New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the hostYingru Liu, Brandon Feinen, Michael W Russell
Mbio|August 29, 2024
Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesisMichael W Russell, Mogens Kilian, Jiri Mestecky
Clinical and Vaccine Immunology : CVI|November 8, 2013
Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometryWeiwei Zhao, Hans Minderman, Michael W Russell
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Perspectives on mucosal vaccines: is mucosal tolerance a barrier?Jiri Mestecky, Michael W Russell, Charles O Elson
The Journal of Infectious Diseases|September 20, 2013
Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12Yingru Liu, Nejat K Egilmez, Michael W Russell
Iucrdata|November 8, 2023
6,7-Diphenyl-5-thia-7-aza-spiro-[2.6]nonan-8-one 5,5-dioxideHemant P Yennawar, Michael W Russell, Lee J Silverberg
Vaccine|September 11, 2013
Vaccines against gonorrhea: current status and future challengesAnn E Jerse, Margaret C Bash, Michael W Russell
Infection and Immunity|June 24, 2005
Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in miceGregory A Price, Michael W Russell, Cynthia Nau Cornelissen
Biochemical and Biophysical Research Communications|July 29, 2008
ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21Michael W Russell, Mohamed A Soliman, David Schriemer, et al.
Pageof 5